Curriculum Vitae, Clark L. Anderson
Curriculum Vitae, Clark L. Anderson
October 15, 2017
CURRICULUM VITAE
Name:Clark Lawrence Anderson
S.S. Number:577524840
Present Position:Professor
Division of Immunology
Department of Internal Medicine
College of Medicine, The OhioStateUniversity
Mail:The OhioStateUniversity
012k The Heart & Lung Research Institute
473 West Twelfth Avenue
Columbus, OH43210
Voice: 614-2477650
Fax: 614-247-7669
Internet:
Beeper: 614-730-6739
Website:
Faculty Appointments:
19771983Assistant Professor of Medicine; University of RochesterSchool of Medicine, Rochester, NY
19821986Assistant Professor of Microbiology; University of RochesterSchool of Medicine, Rochester, NY
19831986Associate Professor of Medicine; University of RochesterSchool of Medicine, Rochester, NY
19862005Professor, Department of Internal Medicine (primary); The Ohio State University College of Medicine, Columbus, OH
1987-Professor, Department of Molecular and Cellular Biochemistry (secondary); The Ohio State University College of Medicine, Columbus, OH
1987-1998Professor, Department of Molecular Genetics (secondary); The Ohio State University College of Biological Sciences, Columbus, OH
2005-Professor Emeritus, OSU Department of Internal Medicine.
Education:
19551957BrownUniversity, Providence, Rhode Island
19571960University of Arizona, Tucson, AZ, B.A., 1960
19601964University of Chicago, School of Medicine, M.D., 1964
19641965University of Chicago, Department of Biochemistry, Ph.D. student
Armed Services:
1966-1969Major, U.S. Army Medical Corps, Vietnam War Doctors’ Draft
Clinical Training
19651966Internship in Internal Medicine; Dr. Gordon Meiklejohn, University of Colorado, Denver, CO
19691971Residency in Internal Medicine; Dr. Gordon Meiklejohn, University of Colorado, Denver, CO. Board Qualified
19741975Fellowship in Clinical Immunology; Dr. Richard Farr; National Jewish Center and University ofColorado, Denver, CO
Research Training:
19711972Postdoctoral Research Fellowship in Immunology; Drs. Percy Minden and Richard Farr; National Jewish Center, Denver, CO
19721974Research Fellowship in Immunology; Dr. Howard Grey; National Jewish Center, Denver, CO
19751977Leukemia Society of America Special Fellowship; Dr. Grey
Licensure:
National Board of Medical Examiners
Colorado, #16972
New York, #130699
Ohio, #54371
Honors and Awards:
1960High honors with baccalaureate degree; U. Arizona
1960Phi Kappa Phi National Scholastic Honorary, U. Arizona
19751977Leukemia Society of America Special Fellowship, U. Colorado
1978Buswell Foundation Faculty Award; U. Rochester
19791984Research Career Development Award, NIAID, NIH
1981WHO Nomenclature Committee on Fc Receptors
1982-Ad Hoc Reviewer: NIH study sections and site visits, National Science Foundation, Veterans Administration, Canadian Red Cross, The Netherlands NIH, Biochemistry Journal, Journal of Clinical Immunology, Science, Journal of Clinical Investigation, Journal of Leukocyte Biology, Cellular Immunology, Journal of Immunology, Blood, Journal of Pediatric Infectious Diseases, Journal of Immunopharmacology, Immunity, PNAS, Journal of Experimental Medicine, Journal of Molecular Evolution, Journal of Biological Chemistry, Gene, Austrian Science Fund, Molecular and Cellular Biology, Biotechnology and Bioengineering, Hungarian Scientific Research Fund, Journal of Histochemistry & Cytochemistry, Analytical Biochemistry, Journal of Pharmacology and Experimental Therapeutics, Nature Reviews Nephrology, BioMed Research International, PLoS One, Structure
1987-1991Medical Biochemistry Study Section (2), DRG, NIH, regular member
1988-1995Member Board of Scientific Directors, Medarex, Inc., Annandale, NJ
1989-1998Associate Editor, Journal of Clinical Immunology
1992V International Leukocyte Workshop, Cluster Co-Chairman
1994Distinguished Scholar Award; OSU
1996Journal of Leukocyte Biology Outstanding Review Award
1998-2002Section Editor, Journal of Immunology
National Professional Organizations:
1975-1991American Academy of Allergy and Clinical Immunology
1976-1991American Federation for Clinical Research
1976-American Association of Immunologists
1986-1993Reticuloendothelial Society
1987-1994American Society for Cell Biology
University Committees and Offices:
1988-1990The OSU Medical Scientist Program (M.D./Ph.D. program), Director
1988-1991The OSU Faculty Senate
1988-1991The OSU Medical Faculty Caucus
1989The OSU Search Committee for Dean of College of Biological Sciences
1992-1994College of Medicine Graduate Education Committee
1992-1996Dept Medicine Promotions and Tenure Committee; Chair, 1995-1996.
1993-OSUCollege of Medicine Research Committee
1993-OSU Department of Medicine Research Space Committee
1994College of Medicine Search Committee for Chair of Department of Medical Biochemistry.
1994-Department of Medicine Ad Hoc Committee on Promotions Criteria
1995-1996OSU Research Foundation Principal Investigator Advisory Committee
1996-1997Advisory Committee for the Molecular Medicine Initiative
2001-Department of Medicine Committee on Incentives
2003-Department of Medicine Research Committee
2011-2013HLRI Space Committee
Invited Presentations at National or International Meetings (date, event, place, host):
4/86; Minisymposium, FASEB Annual Meeting; St. Louis, MO
4/86; FASEB Annual Meeting; St. Louis, MO
7/86; Fc Receptor Symposium; Toronto, Canada
7/86; VI International Congress Immunology; Toronto, Canada
9/86; Reticuloendothelial Society; Denver, CO
6/87; FASEB Summer FcR Conference, Saxtons River, VT
9/87; Platelet Immunology Conference; Milwaukee, WI
3/88; Sandoz symposium on Monoclonal Antibodies; Amsterdam, The Netherlands
4/88; Joint French and British Societies of Immunology; Paris, France
4/88; British Society of Biochemistry; Sheffield, England
5/88; Minisymposium Chair; FASEB Annual Meeting; Las Vegas, NV
5/88; Presentation; FASEB Annual Meeting; Las Vegas, NV
3/89; Sandoz Symposium on Autoimmunity; Scottsdale, AZ; Dr. Irwin Gelfand
3/89; Faseb Annual Meeting; New Orleans, LA
10/89; Society of Leukocyte Biology; MarcoIsland, FL
7/90; FASEB Summer FcR Conference, Copper Mountain, CO
7/90; Poster; FASEB Summer Conference; Copper Mountain, CO (G. Anderson, Ph.D.)
7/90; Poster; FASEB Summer Conference; Copper Mountain, CO (G. Kindt, Ph.D.)
9/91; Pediatric AIDS Foundation; Santa Barbara, CA; Arthur Ammann, M.D.
4/92; FASEB Annual Meeting; Anaheim, CA
8/92; VIII International Congress Immunology; Budapest, Hungary
11/93; V International CD Workshop; Boston, MA
2/96; Oral Immunology and Microbiology Research Group; Orlando; Gary Wilson, Ph.D.
3/97; North American Trophoblast Meeting, San Diego; Nicholas Illsley, Ph.D.
11/01; American College Rheumatology; San Francisco; Jane Salmon, M.D. (cancelled, illness)
6/02; Frontiers in Reproduction; Boston; Joan Hunt, Ph.D.
7/02; Society for the Study of Reproduction; Baltimore; Joan Hunt, Ph.D.
5/03; The Karl Landsteiner Lecture; CLB; Amsterdam, NL; Masja de Haas, Ph.D.
9/03; Howard M. Grey Festschrift; LaJolla, CA; Mitch Kronenberg, Ph.D.
6/06; AAPS National Biotechnology Conference: Boston; Joseph Balthasar, Ph.D.
8/08; International Society Hepatic Sinusoidal Research; Tromso, Norway
3/10; Gordon Conference on Antibody action; Ventura, CA
8/10; International Society Hepatic Sinusoidal Research; Pasadena, CA
Presentations at Other Academic Institutions:
3/86; Dept Medicine; Rush Medical Colege; Henry Gewurz, M.D., Ph.D.
3/86; Dept Medicine, Univ Illinois; John Scosey, M.D., Ph.D.
1/87; Cetus Immune, Inc.; Palo Alto, CA; David Ring, Ph.D.
1/87; Dept Medicine; UCSF; San Francisco, CA; Gary Peltz, M.D., Ph.D.
2/87; Dept Pathology; Univ Iowa; Iowa City, IO; Richard Lynch, M.D.
3/87; Dept Micro, Dartmouth Conference; Squam Lake, VT; Michael Fanger, Ph.D.
4/87; Dept Genetics; Univ Turino; Torino, Italy; Fabio Malavasi, M.D.
4/87; Dept Pharm; Univ Milan; Milan, Italy; Paolo Ricciardi-Castagnoli, Ph.D.
6/87; Proctor & Gamble; Cincinnati, OH; Robert Singer, Ph.D.
6/87; Medarex, Inc. Minary Conf Center; Squam Lake, VT; Michael Fanger, Ph.D.
6/88; Medarex, Inc. Minary Conf Center; Squam Lake, VT; Michael Fanger, Ph.D.
6/88; Dept Micro; DartmouthMedicalSchool; Michael Fanger, Ph.D.
11/88; Dept Medicine; University of Rochester; R. John Looney, M.D.
11/88; Dept Chemistry, CornellUniversity; Barbara Baird, Ph.D.
3/88; Dept Medicine; Univ Leuven; Leuven, Belgium; Jan Ceuppens, M.D., Ph.D.
3/88; Dept Medicine; University Nihmegen, Nijmegen, Netherlands; Wil Tax, Ph.D.
3/88; RedCrossBloodCenter; Amsterdam, The Netherlands; Pedro Tetteroo, Ph.D.
3/88; Centocor Europe, B.V.; Leiden, The Netherlands; Pedro Tetteroo, Ph.D.
10/89; Medarex, Inc. Minary Conference; Squam Lake, NH; Michael Fanger, Ph.D.
5/90; Dept Micro; Univ Kansas; Kansas City, KA; Tsuneo Susuki, M.D., Ph.D.
6/90; Minary FcR Symposium; Squam Lake, NH; Michael Fanger, Ph.D.
5/91; Minary FcR Conference; Squam Lake, NH; Michael Fanger, Ph.D.
9/91; Dept Bioscience; UCSB, Santa Barbara, CA; Duane Sears, Ph.D.
8/92; Dept Immunology; Univ Utrecht, The Netherlands; Jan Van de Winkel, Ph.D.
3/93; Immunol Program; Univ Cincinnati; OH; Alvin E. Davis, M.D.
4/93; Univ Wisconsin; Milwaukee, WI; Richard Aster, M.D.
6/93; Immunology Program; Case-Western Reserve; Michael Tosi, M.D.
7/93; Scripps Clinic and Research Foundation; John Curnutte, M.D., Ph.D.
10/93; Dept Immunol; Univ Toronto, Toronto, Canada; Michel Klein, M.D.
12/95; Dept Microbiology; Dartmouth, Lebanon, NH; Michael Fanger, Ph.D.
5/97; Jackson Laboratories Research Institute, Bar Harbor, ME, Derry Roopenian, Ph.D.
10/97; Cornell University Medical Center, New York City, NY, Jane Salmon, M.D.
1/98; Immunology Program; Univ. of Pittsburgh, Pittsburgh, PA; Penelope Morel, M.D.
11/99; Immunology; Univ. New Mexico, Albuquerque, NM; Terry DuClos, M.D.,Ph.D.
10/02; Immunology; AlbanyMedicalCollege, Albany, NY; Edward Gosselin, Ph.D.
12/02; Biogen, Inc.; Cambridge, MA; Graham Farrington, Ph.D.
10/03; LaJolla Inst Allergy & Immunology; CA; Howard Grey, M.D.
5/03; Genmab, Inc.; Utrecht, NL; Jan van de Winkel, Ph.D.
4/04; Dept Pathology; EmoryUniversity; Atlanta, GA; Periasamy Selvaraj, Ph.D.
10/05; SUNY Buffalo; Joseph Balthasar, Ph.D.
9/06; John P. Leddy Festschrift; Rochester, NY; Ignacio Sanz, M.D. cancelled;
10/06; Amgen Mountain View (Avidia); CA; Kevin Moore, Ph.D.
5/07; Adnexus Therapeutics; Boston; Eric Furfine, Ph.D.
5/08; Merck, Philadelphia; Thomayant Prueksaritanont, Ph.D.
1/12; St.Louis University; Mark Buller, PhD.
Presentations at OhioStateUniversity:
10/86; Immunology Seminar Series, Col of Med; Rolf Barth, M.D.
11/86; Dept Physiol Chem; Col of Med; Gerald Brierley, Ph.D.
1/87; Dept Micro; Col of Biosci; Richard Mortensen, Ph.D.
11/87; Dept Biochemistry; Col of Biosci; George Marzluf, Ph.D.
1/88; MolGen 705; Col of Biosci; Berl Oakley, Ph.D.
1/89; Immunology Seminar Series; Col of Med; Rolf Barth, M.D.
2/89; MolGen705; Col of Biosci; Berl Oakley, Ph.D.
3/89; Dept Surgery; Col of Med; Charles Orosz, Ph.D.
2/90; MolGen 705; Col of Biosci; Berl Oakley, Ph.D.
11/91; Dept Micro and Immunol; Col of Med; Ronald Glaser, Ph.D.
2/92; MolGen 705; Col of Biosci; Berl Oakley, Ph.D.
2/93; MolGen 705; Col of Biosci; Berl Oakley, Ph.D.
2/95; Dept Med Biochemistry; Col of Med; Gerald Brierly, Ph.D
4/95; Dept Medicine Grand Rounds; Ernest Mazzaferri, M.D.
6/95; Grants Colloquium; Col of Med; Daniel Sedmak, M.D.
12/95; Dept Ob/Gyn; Col of Med; Steven Gabbe, M.D.
1/96; Immunology Program; Rolf Barth, M.D.
2/98; Dept Microbiology; Col of Biosci: Mark Coggeshall, Ph.D.
4/98; Heart-Lung Institute; Mark Wewers, M.D.
…record not continued
Trainees: Postdoctoral fellows and Ph.D. students trained by Dr. Anderson: Listed chronologically by name, degrees and institution; position and dates in my lab; last known whereabouts. List prepared March 31, 2003; last updated October 12, 2007: At last count 11/31of my trainees had academic jobs.
Postdoctoral fellows:
Charles Beauchamp, M.D. Ph.D. Duke; fellow 1979-1980; General Medicine, University of Michigan
Linda Ludwig, M.D. Rochester; fellow 1982; Department of Pediatrics, University of Rochester, NY
Douglas H. Jones, M.D. Johns Hopkins; fellow 1982-1985; Adjunct Assistant Professor, U. Rochester.
R. John Looney, M.D. Rochester; fellow 1984-1986; Professor, Department of Medicine, U. Rochester.
George Anderson, Ph.D. OSU; fellow 1987-1990, NRSA; Scientist, Naval Research Lab;Wash D.C.
Gary Kindt, M.D. OSU; fellow 1988-1990; private practice, pulmonary medicine, MI
Donald M. Eicher, M.D. OSU; fellow 1989-1990; Assistant Professor, Case Western Reserve
Sharda Hebbar, Ph.D. OSU; fellow 1989; leave of absence
Jan van de Winkel, Ph.D. Nijmegen; fellow 1990-1991; Professor, Utrecht, NL; CEO Genmab Inc.
Alaa Ahmed, Ph.D. Glasgow; fellow 1991-1993; Research Scientist, University of Glasgow, Scotland
Nagaradona Harindranath, Ph.D.; fellow 1992-1994; Staff Scientist, NIH
Linda Ernst, Ph.D. Utrecht; student, fellow 1988-1995; Asst Professor, U. Pittsburgh, PA, LOA.
Anne-Marie Duchemin, M.D. Paris; fellow 1991-1996; Research Associate Professor, OSU
Kathleen Miller, Ph.D. OSU; fellow 1997-1998; Staff Scientist, DNAX, Palo Alto, CA
Timothy Lyden, Ph.D. Maine; fellow 1998-2001; Assistant Professor; U. Wisconsin River Falls.
Susheela Tridandapani, Ph.D. OSU; fellow 1998-2001; LLS Fellow 2000-2003; Professor; OSU
Samina Mehnaz, Ph.D. Pakistan; fellow 2000-2003; Assoc Prof. Univ Punjab. Lahore, Pakistan
Cynthia L. Bronson, Ph.D. OSU; fellow 2002-2005; Lecturer OSU Department of EEOB.
Sudha Mohanty, Ph.D.JawaharlalNehruUniversity, New Delhi; fellow 2003-present
Jonghan Kim, Ph.D. OSU; fellow 2004-2007. Fellow Harvard. Dr. Wessling-Resnick lab.
Chaity Chaudhury, Ph.D. OSU; fellow 2005-2006;Scientist Medimmune; Gaithersburg, MD.
Latha P. Ganesan, Ph.D. Madurai Kamaraj Univ; fellow 2007-present.
Jessica Mates, Ph.D. OSU Virologist. 2014 – 2016
Zhili Yao, Ph.D. OSU Organic Chemist. 2015 – present
Osan Suer, M.D. Case Western. 2016 - present
Graduate Students for the Ph.D. degree:
George Chacko, Ph.D. OSU in Biochem; student 1990-1995. SRA; NIH; Bethesda, MD.
Linda Ernst, Ph.D. Utrecht in Immunol.; student 1989-1995. Left science after Asst. Prof, U. Pittsburgh
Diane Maresco, Ph.D. OSU in MolGen; student 1991-1997. Scientist Queensland U., Brisbane, AU
Kathleen Miller, Ph.D. OSU in MolGen; student 1991-1997. Staff Scientist, DNAX, Palo Alto, CA
Malcolm Lowry, Ph.D. OSU in MolGen; student 1992-1998. Asst Prof, OregonStateUniversity.
Chaity Chaudury, Ph.D. OSU in Biochem; student 2000-2005. Fellow UCSF. Douglas Hanahan lab.
Jonghan Kim, Ph.D.OSU in Pharmacokinetics 2002-2004. Fellow Harvard. Dr. Wessling-Resnick lab.
Other Students:
James H. O’Grady, M.S.; Rochesterstudent for MS degree in lab; 1983-1985. Kodak, Inc.
Scott Aberegg, M.D.; OSUmed student in lab; 1994-1996. Asst Prof. OSU Dept of Med.
James Leach, M.S.; OSU biochemistry student for MS degree in lab; 1995-1997. Ross Labs., Inc.
Patents: Medarex, Inc. 1985. In the early 1980s I along with Michael Fanger and Paul Guyre of Dartmouth collaborated to start a biotech company to develop two monoclonal antibodies that I had made with their help, mabs 32 and IV.3, directed toward human Fc receptors, antibodies on which I and U of Rochester colleagues held the patents. Wanting to avoid commercial distractions I dropped out of the collaboration, but Mike and Paul went on to establish and develop Medarex, Inc, which became a huge success, being traded on Nasdaq and eventually being sold to Bristol-Meyers in 2009 for $2.4 billion. The company makes therapeutic human antibodies to microbes and cancers. I consider myself the foster father of this biotech company.
Publications: (in parentheses, citations as of August 30, 2005)
Anderson, C.L., and H.M. Grey. 1974. Receptors for aggregated IgG on mouse lymphocytes: Their presence on thymocytes, thymus derived and bone marrow derived lymphocytes. J. Exp. Med. 139:1175-1188. (245)
Anderson, C.L., R.T. Kubo, and H.M. Grey. 1975. Cytophilic properties of 2-microglobulin. J. Immunol. 114:997-1000. (33)
Grey, H.M., C.L. Anderson, C.H. Heusser, and J.T. Kurnick. 1975. Fc receptors on lymphocytes other than B cells in mouse and man. In Membrane Receptors of Lymphocytes. M. Seligmann, J.L. Preud'homme and F.M. Kourilski, editors. North Holland Publishing Co., The Netherlands, published by Elsevier Exerpta Medica in the INSERUM Symposia Series, 1:185-192.
Grey, H.M., C.L. Anderson, K. Von Eschen, C. Heusser, and J. Chiller. 1977. Structural and functional heterogeneity of Fc receptors. ColdSpringHarbor Symposia on Quantitative Biology, Vol. XLI, p. 315-321.
Anderson, C.L., and H.M. Grey. 1977. Solubilization and partial characterization of cell membrane Fc receptors. J. Immunol. 118:819-825. (50)
Heusser, C.H., C.L. Anderson, and H.M. Grey. 1977. Receptors for IgG: Subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line. J. Exp. Med. 145:13161327. (195)
Anderson, C.L., and H.M. Grey. 1978. Physicochemical separation of two distinct Fc receptors on mouse macrophagelike cell lines. J. Immunol. 121:648652. (48)
Grey, H.M., and C.L. Anderson. 1980. Structural characteristics of Fc receptors on macrophages. In Mononuclear Phagocytes: Functional Aspects. R. Van Furth, editor. Martinus Nijhoff Publishing Co., The Hague, pp. 757-776.
Anderson, C.L. 1980. The murine macrophage Fc receptor for IgG2b is lipid dependent. J. Immunol. 125:538540. (7)
Anderson, C.L., and W.S. Stillman. 1980. The Raji cell assay for immune complexes. Evidence for detection of Rajidirected immunoglobulin G antibody in sera from patients with systemic lupus erythematosus. J. Clin. Invest. 66:353360. (69)
Anderson, C.L., and G.N. Abraham. 1980. Characterization of the Fc receptor for IgG on a human macrophage cell line, U937. J. Immunol. 125:27352741. (148)
Anderson, C.L., and H.L. Spiegelberg. 1981. Macrophage receptors for IgE: Binding of IgE to specific IgE Fc receptors on a human macrophage cell line, U937. J. Immunol. 126:24702473. (89)
Goldberg, M.J., M.M. Kaplan, C.L. Anderson, T. Mitamura, D.S. Matloff, V.W. Pinn, and V. Agnello. 1982. Evidence against an immune complex pathogenesis of primary biliary cirrhosis. Gastroenterology 83:677683. (25)
Anderson, C.L. 1982. Isolation of the receptor for IgG from a human monocyte cell line (U937) and from human peripheral blood monocytes. J. Exp. Med. 156:17941806. (120)
Anderson, C.L. 1983. Characterization of human macrophage Fc receptors: Binding of IgG and IgE to the macrophage line, U937. In The Structure and Function of Fc Receptors. F. Paraskevas and A. Froese, editors. Marcel Dekker, Inc., pp. 3352.
Livingston, J.N., B.R. Saran, C.D. Rose, and C.L. Anderson. 1985. Rapid effect of insulin on the cycling of the insulin receptor in a human monocyte cell line (U937). Diabetes 34:403408. (9)
Anderson, C.L., J.M. Spence, T.S. Edwards, and J. Nusbacher. 1985. Characterization of a polyvalent antibody directed against the IgG Fc receptor of human mononuclear phagocytes. J. Immunol. 134:465470. (23)
Jones, D.H., J. Nusbacher, and C.L. Anderson. 1985. Fc receptormediated binding and endocytosis by human mononuclear phagocytes: Monomeric IgG is not endocytosed by U937 cells and monocytes. J. Cell Biol. 100:558564. (29)
Jones, D.H., R.J. Looney, and C.L. Anderson. 1985. Two distinct classes of IgG Fc receptors on a human monocyte line (U937) defined by differences in binding of murine IgG subclasses at low ionic strength. J. Immunol. 135:33483353. (112)
Rosenfeld, S.I., R.J. Looney, J.P. Leddy, D.C. Phipps, G.N. Abraham, and C.L. Anderson. 1985. Human platelet Fc receptor for IgG: Identification as a 40 kD membrane protein shared by monocytes. J. Clin. Invest. 76:23172322. (200)
Looney, R.J., G.N. Abraham, and C.L. Anderson. 1986. Human monocytes and U937 cells bear two distinct Fc receptors for IgG. J. Immunol. 136:16411647. (372)
Looney, R.J., D.H. Ryan, K. Takahashi, H.B. Fleit, H.J. Cohen, G.N. Abraham, and C.L. Anderson. 1986. Identification of a second class of IgG Fc receptors on human neutrophils: A 40 kD molecule found also on eosinophils. J. Exp. Med. 163:826836. (183)
Anderson, C.L., P.M. Guyre, J.C. Whitin, D.H. Ryan, R.J. Looney, and M.W. Fanger. 1986. Monoclonal antibodies to Fc receptors for IgG on human mononuclear phagocytes: Antibody characterization and induction of superoxide production in a monocyte cell line. J. Biol. Chem. 261:1285612864. (277)
O'Grady, J.H., R.J. Looney, and C.L. Anderson. 1986. The valence for ligand of the human mononuclear phagocyte high affinity IgG Fc receptor is one. J. Immunol. 137:23072310. (17)
Anderson, C.L., and R.J. Looney. 1986. Review: Human Leukocyte IgG Fc Receptors. Immunology Today 7:264266. (450)
Shen, L., P.M. Guyre, C.L. Anderson, and M.W. Fanger. 1986. Heteroantibody mediated cytotoxicity: Antibody to the high affinity Fc receptor for IgG mediates cytotoxicity by human monocytes which is enhanced by gamma interferon and is not blocked by human IgG. J. Immunol. 137:33783383. (92)
Anderson, C.L., and R.J. Looney. 1987. IgG Fc receptors of human leukocytes. In Meth. Enz. Vol. 150:524-536, 1987. (20)
Anderson, C.L., D.H. Ryan, R.J. Looney, and P.C. Leary. 1987. Polymorphism of the human monocyte 40 kD receptor for IgG. J. Immunol. 138:2254-2256. (105)
Rosenfeld, S.I., D.H. Ryan, R.J. Looney, C.L. Anderson, G.N. Abraham, and J.P. Leddy. 1987. Human platelet Fc receptors: Quantitative expression correlates with functional responses. J. Immunol. 138:2869-2873. (54)
Looney, R.J., C.L. Anderson, D.H. Ryan and S.I. Rosenfeld. 1987. Structural polymorphism of the human platelet Fc receptor does not correlate with variations in quantitative expression. J. Immunol. 141:2680-2683. (29)
Ceuppens, J.L., M.L. Baroja, F.V. Vaeck and C.L. Anderson. 1988. A defect in the membrane expression of high affinity 72 kD Fc receptors on phagocytic cells in four healthy subjects. J. Clin. Invest. 82:571-578. (53)
Rosenfeld, S.I. and C.L. Anderson. 1989. Fc receptors of human platelets. In Platelet Immunology. Editors T.J. Kunicki and J.N. George. J.B. Lippincott, Philadelphia. pp 337-353.
Peltz, G., K. Frederick, C.L.Anderson and B.M. Peterlin. 1988. Characterization of the human monocyte high affinity Fc receptor. Mol. Immunol. 25:243-250. (25)
Anderson, C.L. 1989. Human leukocyte Fc receptors for IgG: Three distinct classes. In Clinical Uses of Monoclonal Antibodies, Editors R.A.P. Koene and W.J.M. Tax. Sandoz b.v. Uden. Pages 23-29.
Anderson, C.L. 1989. Structural and functional polymorphism of human Fc receptors for IgG. In Chemical Immunology 47:1-20. (26)
Anderson, C.L. 1989. Human IgG Fc receptors. Clin. Immunol. and Immunopath. 53:S63-S71. (47)
Petty, H.R., J.W. Francis and C.L. Anderson. 1989. Cell surface distribution of Fc receptors II and III on living human neutrophils before and during antibody dependent cellular cytotoxicity. J. Cell. Physiol. 141:598-605. (29)
Anderson, G.P. and C.L. Anderson. 1990. Signal transduction by the platelet Fc receptor. Blood. 76:1165-1172. (75)
Ravetch, J.V. and C.L. Anderson. 1990. The FcR family: Proteins, transcripts and genes. In Fc Receptors and the Action of Antibodies. Ed. H. Metzger, American Society of Microbiology. pp 211-238.
van de Winkel, J.G.J. and C.L. Anderson. 1990. Biological Functioning of Human IgG Fc Receptors. Ann. Inst. Pasteur, Forum d'Immunologie. 141:64-67.
Gosselin, E.J., M.F. Brown, C.L. Anderson,T.F. Zipf, and P.M. Guyre. 1990. The Monoclonal Antibody 41H16 Detects the Leu-4 Responder Form of Human FcRII. J. Immuno. 144:1817-1822. (88)
Anderson, C.L., L. Shen, D.M. Eicher, M.D. Wewers, and J.K. Gill. 1990. Phagocytosis mediated by three distinct Fc receptor classes on human leukocytes. J. Exp. Med. 171:1333-1346. (168)
Anderson, C.L., R.J. Looney, D.J. Culp, D.H. Ryan, H.B. Fleit, M.J. Utell, M.W. Frampton, P.D. Manganiello, and P.M. Guyre. 1990. Alveolar and peritoneal macrophages bear three distinct classes of Fc receptors for IgG. J. Immunol. 145:196-201. (47)